DuPont de Nemours Inc Stock

$75.79

1.47%

NYSE, Sep 02, 10:00 pm CET

ISIN

US26614N1028

Symbol

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Materials

Industry

Chemicals

Overview Dividends Analysts Charts News Strategies

DuPont de Nemours Inc Stock price

$75.79

+15.63 25.98% 5Y

NYSE, Closing price Tue, Sep 02 2025

-1.13 1.47%

ISIN

US26614N1028

Symbol

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Materials

Industry

Chemicals

Key metrics

Basic

Market capitalization

$31.7b

Enterprise Value

$37.1b

Net debt

$5.3b

Cash

$1.8b

Shares outstanding

418.7m

Valuation (TTM | estimate)

P/E

negative | 16.7

P/S

2.5 | 2.4

EV/Sales

2.9 | 2.8

EV/FCF

28.0

P/B

1.4

Dividends

DPS

$1.52

Yield 1Y | 5Y

2.0% | 1.9%

Growth 1Y | 5Y

5.6% | 6.3%

Payout 1Y | 3Y

91.0% | 29.8%

Increased

3 Years

Financials (TTM | estimate)

Revenue

$12.6b | $13.2b

EBITDA

$2.7b | $3.4b

EBIT

$2.1b | $2.7b

Net Income

$-194.0m | $1.9b

Free Cash Flow

$1.3b

Growth (TTM | estimate)

Revenue

4.6% | 6.8%

EBITDA

13.7% | 37.6%

EBIT

20.0% | 42.6%

Net Income

-129.2% | 170.2%

Free Cash Flow

7.7%

Financial Health

Equity Ratio

63.7%

Return on Equity

3.0%

ROCE

6.6%

ROIC

1.4%

Debt/Equity

0.3

EPS

$-0.5

FCF per Share

$3.2

Short interest

1.1%

Employees

24k

Rev per Employee

$520.0k

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Get Started for Free Today

DuPont de Nemours Inc Stock Analysis

Unlock Scores for Free

??

26 Analysts have issued a DuPont de Nemours Inc forecast:

21x Buy

81%

5x Hold

19%

More details on Analyst Estimates Including Price Targets

26 Analysts have issued a DuPont de Nemours Inc forecast:

Buy

81%

Hold

19%

Analyst Estimates with Stock Price Targets

Financial data from DuPont de Nemours Inc

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	12,607 12,607	5% 5% 100%
- Direct Costs	7,899 7,899	2% 2% 63%
Gross Profit	4,708 4,708	8% 8% 37%
- Selling and Administrative Expenses	1,524 1,524	1% 1% 12%
- Research and Development Expense	551 551	7% 7% 4%
EBITDA	2,657 2,657	14% 14% 21%
- Depreciation and Amortization	581 581	4% 4% 5%
EBIT (Operating Income) EBIT	2,076 2,076	20% 20% 16%
Net Profit	-194 -194	129% 129% -2%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

DuPont de Nemours Inc Stock News

Neutral

PRNewsWire

●

about 10 hours ago

DuPont Announces Commencement of Exchange Offers and Consent Solicitations for Senior Notes

WILMINGTON, Del. , Sept. 2, 2025 /PRNewswire/ -- DuPont de Nemours, Inc. (NYSE: DD) ("DuPont") announced today the commencement of offers to exchange any and all of its outstanding senior notes of the series listed in the table below (the "Existing Notes") for new notes to be issued by DuPont (the "New Notes").

Neutral

PRNewsWire

●

5 days ago

Arclin Enters into Definitive Agreement to Acquire Aramids Business, including Kevlar® and Nomex® Brands, from DuPont™

Acquired brands to broaden and complement Arclin's innovation platform ALPHARETTA, Ga. , Aug. 29, 2025 /PRNewswire/ -- Arclin announced today it has entered into a definitive agreement to acquire DuPont's Aramids business, which includes the Kevlar® and Nomex® brands, for approximately $1.8 billion.

Neutral

PRNewsWire

●

5 days ago

DuPont Announces Agreement to Divest Aramids Business to Arclin

Transaction structure maximizes shareholder value, enables participation in future upside potential of combined new entity Divestiture further streamlines the new DuPont portfolio and improves its financial profile WILMINGTON, Del. , Aug. 29, 2025 /PRNewswire/ -- DuPont (NYSE: DD) today announced that Arclin, a portfolio company of an affiliate of TJC, L.P.

More DuPont de Nemours Inc News

Company Profile

DuPont de Nemours, Inc. operates as a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics & Imaging; Nutrition & Biosciences; Transportation & Industrial; Safety & Construction, and Non-Core. The Electronics & Imaging segment provides permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, electroless and electrolytic metallization solutions, as well as patterning solutions and materials and innovative metallization processes for metal finishing, decorative, and industrial applications. The Nutrition & Biosciences segment provides solutions for the global food and beverage, dietary supplements, pharma, home and personal care, energy and animal nutrition markets. The Transportation & Industrial segment engineering resins, adhesives, silicones, lubricants and parts to engineers and designers in the transportation, electronics, healthcare, industrial and consumer end-markets to enable systems solutions for demanding applications and environments. The Safety & Construction segment provides engineering products and integrated systems for a number of industries including, worker safety, water purification and separation, aerospace, energy, medical packaging and building materials. The Non-Core segment supplier of key materials for the manufacturing of photovoltaic cells and panels, including SOLAMET metallization pastes, TEDLAR backsheet materials, and FORTASUN silicone encapsulants and adhesives. The company was founded on September 1, 2017 and is headquartered in Wilmington, DE.

Head office	United States
CEO	Lori Koch
Employees	24,000
Founded	1897
Website	www.dupont.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now